FABP4 modulates lipid metabolism of ovarian cancer cells by destroying tumor-infiltrating dendritic cells, thereby interfering with anti-tumor immunity, resulting in poor prognosis of ovarian cancer [76,78]. The gene discussed is FABP4; the disease is neoplasm.